Clinical trial
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin…
NCT00458458 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Unknown status
Key facts
| NCT number | NCT00458458 |
|---|---|
| Title | Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) |
| Official title | Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | State University of New York - Downstate Medical Center National Institutes of Health (NIH) NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometriosis, Dysmenorrhea, Dyspareunia |
| Intervention type | Drug |
| Interventions | Norethindrone Acetate (NA), GnRH Agonist (Lupron Depot) |
| Enrollment | 112 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2012 |
| First posted | Apr 10, 2007 |
| Last update posted | Oct 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: